Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Introduction: Minor psychiatric disorders are important in primary care, because of its high prevalence and consumption of healthcare resources generated.
Objective: Evaluate the effectiveness of rational emotive behavioral therapy (REBT), as an instrument of social work intervention to enhance changes in the parameters of quality of life, medical consultations and drug use in patients with dysthymia.
Design: Multicenter, prospective, not randomized clinical trial, with intervention and control group simultaneously in urban primary care settings and 1 year of follow up.
Participants: Out-patients seen in two Primary Care centers diagnosed with dysthymia according to DSM-IV classification of American Psychiatric Association.
Intervention: Subjects receive up to 8 biweekly individual sessions of thirty minutes of REBT administered by the Social Worker.
Variables: Demographic data, educational level, coexistence, comorbidity, quality of life assessment, severity of depression, number of visits to the General Practitioner (GP) and drug consumption: sedatives / antidepressants.
Expected Results: The expected results of the intervention, estimated from previous data, are:
Potential impact expected: The investigators hope that rational emotive theory is an effective intervention method for handling minor psychiatric disorders in clinical social work.
The calculation of the size of the population sample was performed for the worst case comparison of different outcome variables, so for a final ratio of 8% people taking hypnotics in Intervention Group (IG) versus 37% in the Control Group (CG), with significance level of 5% and a statistical power of 80%, previewing a 20% loss to follow-up and a ratio of 1 control per case, we need 50 individuals in the CG and 50 individuals in the IG.
Regarding to the attendance to primary care centers, was categorized as "improved" and "not improved or remains the same." "Improvement" is when the number of visits decrease over the previous year, comparing baseline data with respect 12 months. Also, improvement in the use of psychotropic medication is when intakes fall in the previous year by comparing baseline data with respect 12 months. When no data were available at 12 months, the comparison was made with data collected at 4 months.
Patients in IG were recruited from primary care center Sant Andreu, while the CG were enrolled in the primary care center in Martorell. The selection of the two groups in separate centers was determined to avoid the possible effects of contamination bias of the CBT-REBT. In the IG, each physician systematically derived patients with inclusion criteria to the social worker. In the CG, the physician made ordinary care task. In both groups, the number of visits to primary care centers and consumption of psychotropic drugs were extracted from the medical record and other information was obtained through interviews at baseline, 4 and 12 months.
All patients signed informed consent at baseline. In order to recruit homogeneous cases, clearly diagnosed and ensure comparability training for all recruiters was conducted. Collection forms and the database did not include confidential information to ensure confidentiality and anonymity, keeping a separately single list with relation to the number of each case.
Access data base was used to systematize the registration data collection and handling errors by different professionals. Previous comparison of baseline data between completers and dropouts, as well as between the IG and CG was performed by Chi-square and mean comparison. A descriptive analysis of baseline variables as frequencies, means, and dispersion measures was carried out. For the analysis of post-intervention improvement in outcome parameters in one group compared with another, only data from the baseline and 12 months were taken into account. Bivariate and multivariate analysis was performed using logistic regression to control for confounding factors. Values less than 0.05 were considered significant. The Statistical Package for the Social Sciences (SPSS) v.18 software was used.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Rational-Emotive-Behavioral Therapy | Experimental | A social worker held eight 30 minutes sessions fortnightly of Rational-Emotive-Behavioral Therapy. First session is informative about the type of treatment to be performed. The next sessions work events, thoughts and feelings with the goal of changing the dysfunctional thoughts by other more rational ones, measured by scales. |
|
| Control Group | Active Comparator | The control group (GC) will take the usual medical care for dysthymia, according with up-dated guidelines. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Rational-Emotive-Behavioral Therapy | Other | A social worker held eight 30 minutes sessions fortnightly. First session is informative about the type of treatment to be performed. The next sessions work events, thoughts and feelings with the goal of changing the dysfunctional thoughts by other more rational ones, measured by scales. |
| Measure | Description | Time Frame |
|---|---|---|
| Change From Baseline in Severity of Depression, Measured According to the Beck Depression Inventory, at 4 and 12 Months. | The Beck Depression Inventory (BDI) consisted of twenty-one questions about how the subject has been feeling in the last week. Each question has a set of at least four possible answer choices, ranging in intensity. When the test is scored, a value of 0 to 3 is assigned for each answer and then the total score is compared to a key to determine the depression's severity. The standard cut-offs are as follows:
| Baseline, month 4, month 12. |
| Measure | Description | Time Frame |
|---|---|---|
| Change From Baseline in Perceived Quality of Life, Measured as Values of Satisfaction With Life Domains Scale (SLDS) at 4 and 12 Months | The Satisfaction with Life Domains Scale (SLDS) is a measure of respondent satisfaction constructed to assess patient's satisfaction regarding 15 life domains. The respondent is asked in each of 15 domains to indicate his/her feelings by choosing one of seven faces ranging from a "delighted" face with a large upturned smile (scored 7) to a "terrible" face with a deep frown (scored 1). The patients are asked to pick the face that best represented their degree of satisfaction with the proposed life areas. The last of the life areas (The place they live in currently compared with the state hospital) has been discarded for our study, because the patients were treated by primary care. The overall scale (summatory of 15 domains) runs from minimum as 0 to maximum as 98 |
| Measure | Description | Time Frame |
|---|---|---|
| Average Number of Visits of Attendance at Medical Visits in Previous Year and 1 Year of Follow up Date. | Attendance means at medical visits were obtained from computerized medical records for a period of one year previous to the baseline date and 1 year of follow up date. | Baseline, 1 year |
| Percentage of People in the Group Who Stop Taking or Reduce the Dose of Psychotropic Drugs at 12 Months |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Carme Rovira Aler, LCSW | Catalan Institute of Health | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Catalan Health Institute. ABS Sant Andreu 9D | Barcelona | 08030 | Spain |
Not provided
Non randomized assignment: patients from Barcelona were assigned to Intervention Group and Patients from Martorell , assigned to Control Group.
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Intervention Group | The intervention group received REBT by the purposely trained Social Worker at Barcelona |
| FG001 | Control Group | the control group received the standard medical care by their General Practitioner (GP) at Martorell |
| Title | Milestones | Reasons Not Completed | |||||
|---|---|---|---|---|---|---|---|
| Baseline |
|
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
|
| Control Group usual care | Other | In the control group the dysthymia is treated as usual with the conventional treatment. |
|
|
| Baseline, month 4, month 12. |
Percentage of people with any improvement in the dosage of psychotropic drugs (sedatives and antidepressants) in the group at 12 months compared to the baseline date of the study. |
| Baseline, months 12 |
| COMPLETED |
|
| NOT COMPLETED |
|
|
| 4 Month |
|
|
| 12 Month |
|
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Intervention Group | The intervention group received REBT by the purposely trained Social Worker at Barcelona |
| BG001 | Control Group | the control group received the standard medical care by their General Practitioner (GP) at Martorell |
| BG002 | Total | Total of all reporting groups |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age, Customized | Mean | Standard Deviation | years |
| |||||||||||||||
| Sex: Female, Male | Count of Participants | Participants |
| ||||||||||||||||
| Educational level | Count of Participants | Participants |
| ||||||||||||||||
| Living arrangements | Count of Participants | Participants |
| ||||||||||||||||
| psychopharmacological agents | This measure take in account if participant takes or not psychopharmacological agents | Count of Participants | Participants |
| |||||||||||||||
| Sedative-hypnotics agents | Count of Participants | Participants |
| ||||||||||||||||
| Antidepressants agents | Count of Participants | Participants |
| ||||||||||||||||
| Anxiolytic agents | Count of Participants | Participants |
| ||||||||||||||||
| Number of visits | Number of visits to GP during previous year | Mean | Standard Deviation | visits |
| ||||||||||||||
| Number of psycopharmacological agents | Number of psycopharmacological agents at baseline | Mean | Standard Deviation | agents |
| ||||||||||||||
| Beck depression inventory score at baseline | The Beck Depression Inventory is used in the detection and quantification of depressive symptoms in patients. It is a paper and pencil self-report made up of 21 Likert-type items. Its items are not derived from any specific theory about the construct measured, but instead describe the most frequent clinical symptoms of psychiatric patients with depression. Cut-off points have been established: [0-9: no depression], [10-18: mild depression], [19-29: moderate depression], [≥30: severe depression] The minimum and maximum scores on the scale are 0 and 63. | Mean | Standard Deviation | scores on a scale |
| ||||||||||||||
| Number of comorbidities | Number of comorbidities at baseline | Mean | Standard Deviation | comorbidities |
|
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Change From Baseline in Severity of Depression, Measured According to the Beck Depression Inventory, at 4 and 12 Months. | The Beck Depression Inventory (BDI) consisted of twenty-one questions about how the subject has been feeling in the last week. Each question has a set of at least four possible answer choices, ranging in intensity. When the test is scored, a value of 0 to 3 is assigned for each answer and then the total score is compared to a key to determine the depression's severity. The standard cut-offs are as follows:
| Posted | Mean | Standard Deviation | score on a scale | Baseline, month 4, month 12. |
|
|
| ||||||||||||||||||||||||||||||||||||
| Secondary | Change From Baseline in Perceived Quality of Life, Measured as Values of Satisfaction With Life Domains Scale (SLDS) at 4 and 12 Months | The Satisfaction with Life Domains Scale (SLDS) is a measure of respondent satisfaction constructed to assess patient's satisfaction regarding 15 life domains. The respondent is asked in each of 15 domains to indicate his/her feelings by choosing one of seven faces ranging from a "delighted" face with a large upturned smile (scored 7) to a "terrible" face with a deep frown (scored 1). The patients are asked to pick the face that best represented their degree of satisfaction with the proposed life areas. The last of the life areas (The place they live in currently compared with the state hospital) has been discarded for our study, because the patients were treated by primary care. The overall scale (summatory of 15 domains) runs from minimum as 0 to maximum as 98 | Posted | Mean | Standard Deviation | score on a scale | Baseline, month 4, month 12. |
|
| |||||||||||||||||||||||||||||||||||||
| Other Pre-specified | Average Number of Visits of Attendance at Medical Visits in Previous Year and 1 Year of Follow up Date. | Attendance means at medical visits were obtained from computerized medical records for a period of one year previous to the baseline date and 1 year of follow up date. | Posted | Mean | Standard Deviation | medical visits attended | Baseline, 1 year |
|
| |||||||||||||||||||||||||||||||||||||
| Other Pre-specified | Percentage of People in the Group Who Stop Taking or Reduce the Dose of Psychotropic Drugs at 12 Months | Percentage of people with any improvement in the dosage of psychotropic drugs (sedatives and antidepressants) in the group at 12 months compared to the baseline date of the study. | Posted | Number | 95% Confidence Interval | Percentatge of people with any improveme | Baseline, months 12 |
|
|
1 year
The occurrence of death due to any cause is the only adverse event reported because this is a psychosocial intervention.
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Rational-Emotive-Behavioral Therapy | A social worker held eight 30 minutes sessions fortnightly of Rational-Emotive-Behavioral Therapy. First session is informative about the type of treatment to be performed. The next sessions work events, thoughts and feelings with the goal of changing the dysfunctional thoughts by other more rational ones, measured by scales. Rational-Emotive-Behavioral Therapy: A social worker held eight 30 minutes sessions fortnightly. First session is informative about the type of treatment to be performed. The next sessions work events, thoughts and feelings with the goal of changing the dysfunctional thoughts by other more rational ones, measured by scales. | 0 | 51 | 0 | 51 | 0 | 51 |
| EG001 | Control Group | The control group (GC) will take the usual medical care for dysthymia, according with up-dated guidelines. Control Group usual care: In the control group the dysthymia is treated as usual with the conventional treatment. | 1 | 39 | 0 | 39 | 0 | 39 |
Not provided
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Principal Investigator: Carme Rovira Aler | Institut Català de la Salut | +34686838979 | crovira.bcn.ics@gencat.cat |
| ID | Term |
|---|---|
| D003863 | Depression |
| D019263 | Dysthymic Disorder |
| ID | Term |
|---|---|
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |
| D003866 | Depressive Disorder |
| D019964 | Mood Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
| Male |
|
| Secondary schooling and University |
|
| Lives with other people |
|
| treatment |
|
| yes |
|
| yes |
|
| yes |
|
| Baseline analysis |
|
| Counts |
|---|
| Participants |
|
|
|
|